biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by Mexymaxon Jan 14, 2020 5:47pm

113 Views

Post# 30553135

RE:Been there ...done it..

Well said Oyster. It is funny that the unconnected and uninformed rage against the more knowledgeable for not knowing everything, not making things happen and not speeding up the process. it is equally funny that they continue to hold a stock they despise. And should the stock become a major winner, they will cry at JD about why it took so long. What awful lives they must lead and now can't buy a winning stock.

Bullboard Posts

Anaergia expands relationship with PepsiCo